Research

rs1137101 — LEPR Q223R (Gln223Arg)

Common leptin receptor variant in the leptin-binding domain affecting satiety signaling and metabolic regulation

Moderate Risk Factor Share

Details

Gene
LEPR
Chromosome
1
Risk allele
G
Protein change
p.Gln223Arg
Consequence
Missense
Inheritance
Codominant
Clinical
Risk Factor
Evidence
Moderate
Chip coverage
v3 v4 v5

Population Frequency

AA
25%
AG
50%
GG
25%

Ancestry Frequencies

east_asian
88%
african
56%
south_asian
49%
european
47%
latino
44%

Related SNPs

Category

Hormones & Sleep

See your personal result for LEPR

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Leptin Receptor Paradox — When Satiety Signals Misfire

Your leptin receptor (LEPR) gene encodes the protein that receives signals from leptin11 leptin
The "satiety hormone" produced by fat cells proportional to energy stores
, the hormone your fat cells release to tell your brain you've had enough to eat. The Q223R variant (rs1137101) is one of the most studied LEPR polymorphisms worldwide — an A-to-G transition at codon 223 that changes a neutral glutamine to a positively charged arginine in the extracellular leptin-binding domain of the receptor. Carriers of the G allele (Arginine-223) show higher circulating leptin levels despite comparable or greater body fat — a hallmark of leptin resistance22 a hallmark of leptin resistance
When leptin rises but fails to suppress appetite, the body compensates by producing more leptin rather than responding to it
.

The Mechanism

The Q223R substitution sits in the cytokine receptor homology 1 (CRH1) domain of the leptin receptor, specifically in the extracellular loop connecting the CRH and fibronectin type III domains where leptin physically contacts its receptor. Glutamine at position 223 is neutral; arginine is positively charged. This charge change alters the local electrostatic environment of the binding interface.

In vitro studies have shown mixed results. The most rigorous functional study — a 2009 paper by Stratigopoulos et al.33 a 2009 paper by Stratigopoulos et al.
Functional consequences of the human leptin receptor Q223R transversion. PubMed 18997673
— used mice expressing humanized LEPR alleles and found no differences in body weight, body composition, energy expenditure, or leptin-induced STAT3 phosphorylation between Q223 and R223 animals. This casts doubt on a direct mechanistic effect at physiological leptin concentrations. However, the R223 allele may affect receptor trafficking, surface expression kinetics, or downstream signaling efficiency under conditions of chronic leptin exposure or energy excess that differ from controlled laboratory settings.

The most reproducible finding in human carriers is elevated circulating leptin levels44 elevated circulating leptin levels
GG carriers consistently show higher plasma leptin in proportion to their adiposity
. This hyperleptinemia without proportional appetite suppression is a defining feature of leptin resistance — the body upregulates leptin production in an attempt to overcome reduced receptor responsiveness. Whether Q223R causes leptin resistance or is merely in linkage disequilibrium with a truly functional variant remains debated.

The Evidence

A 2024 meta-analysis of 39 studies55 2024 meta-analysis of 39 studies
6,099 obesity cases and 6,711 controls across Asian and Caucasian populations
found significant associations across all genetic models for the G allele and obesity: homozygous model (GG vs AA: OR=1.39, 95% CI=1.12–1.73, p=0.003), dominant model (AG/GG vs AA: OR=1.28, p=0.001), and allelic model (G vs A: OR=1.19, p=0.002). Importantly, the association was significant in both Asian and Caucasian subgroups separately, reducing concerns about population stratification confounding.

A Sri Lankan cohort study of overweight and obese adults66 Sri Lankan cohort study of overweight and obese adults
Jayawardena et al. BMC Research Notes, 2020
found GG carriers had 1.3 kg/m² greater BMI (p=0.04) and 3.8 cm greater waist circumference (p=0.03) compared to AA carriers among overweight subjects. The association was not seen in normal-weight individuals, suggesting the variant's effects emerge primarily in the context of energy excess.

Beyond obesity, the G allele has been linked to insulin resistance and metabolic syndrome77 insulin resistance and metabolic syndrome
Gln223Arg associated with HOMA-IR and hyperglycemia in Kyrgyz population: OR=1.83, 95% CI 1.03–3.24
. A meta-analysis of PCOS studies88 meta-analysis of PCOS studies
rs1137101 significantly associated with PCOS susceptibility in Asian populations
found the G allele increased polycystic ovary syndrome risk, consistent with leptin's known role in hypothalamic-pituitary-gonadal axis regulation. In girls, the RR genotype was associated with earlier menarche99 RR genotype was associated with earlier menarche
11.5 years for RR vs 12.0 years for QQ, p<0.05
, suggesting the leptin receptor variant influences pubertal timing.

The G allele frequency varies dramatically by ancestry: roughly 88% in East Asian populations (where GG is the majority genotype), 56% in Africans, 47–49% in Europeans and South Asians, and 44% in Latinos. This high East Asian frequency means GG is the modal genotype in East Asian populations, while carrying different population-attributable risk across ancestry groups.

Practical Actions

The variant's effects on obesity susceptibility appear most pronounced in environments of chronic caloric excess. High-protein diets are particularly relevant for LEPR variants: protein is the macronutrient with the strongest leptin-sensitizing effect at the hypothalamic level — studies show dietary protein at 25–30% of calories reduces spontaneous energy intake by ~400 kcal/day1010 studies show dietary protein at 25–30% of calories reduces spontaneous energy intake by ~400 kcal/day
Weigle et al. Am J Clin Nutr 2005
by amplifying leptin's satiety signal in the arcuate nucleus, independent of changes in leptin levels themselves.

Omega-3 fatty acids (EPA and DHA) are worth highlighting for G allele carriers: PUFA status interacts with leptin receptor variants to modify metabolic syndrome and insulin resistance risk1111 PUFA status interacts with leptin receptor variants to modify metabolic syndrome and insulin resistance risk
Low n-3 plus high n-6 PUFA status amplifies metabolic syndrome risk; high n-3 abolishes genetic risk
. A favorable omega-3 status may partially compensate for the genetic predisposition.

Leptin follows a circadian rhythm, peaking at night. Eating late into the evening misaligns feeding with this rhythm, compounding leptin resistance. Time-restricted eating confined to daylight hours can help preserve the normal leptin secretion pattern.

Interactions

The three most studied LEPR coding variants — K109R (rs1137100), Q223R (rs1137101), and K656N (rs1805094) — occur in partial linkage disequilibrium1212 partial linkage disequilibrium
They're inherited together more often than expected by chance, but not perfectly correlated
. Some studies suggest compound effects from carrying multiple LEPR variants. rs1137100 (K109R) has been studied in relation to metabolic phenotypes and may amplify the Q223R effect when both are present; this would merit a compound action combining GG at rs1137101 with the rs1137100 risk genotype if the individual carries both.

Leptin signaling is also influenced by LEP rs7799039 (G-2548A)1313 LEP rs7799039 (G-2548A)
Encodes more leptin production; carries separate obesity risk
, which affects leptin gene expression levels. Individuals carrying both higher-leptin LEP variants and reduced-responsiveness LEPR variants would be expected to have greater leptin resistance than either alone — another candidate compound interaction.

Finally, leptin cross-talks with the hypothalamic-pituitary axis governing reproductive hormones1414 hypothalamic-pituitary axis governing reproductive hormones
Leptin signals the hypothalamus that energy stores are sufficient for reproduction; impaired signaling delays or disrupts this axis
. G allele carriers, particularly women, may experience leptin-mediated effects on reproductive timing, menstrual regularity, and PCOS risk.

Nutrient Interactions

protein altered_metabolism
omega-3 fatty acids altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant:

AA “Standard Leptin Receptor” Normal

Standard leptin receptor function with normal satiety signaling

You have two copies of the A allele (glutamine at position 223), the ancestral form of the leptin receptor found in the leptin-binding domain. This is the less common genotype in East Asian populations (about 1% frequency there) but represents roughly 25–31% of Europeans and South Asians. Your leptin receptor carries the standard charge profile at position 223, supporting normal leptin binding and typical hypothalamic satiety signaling. Research consistently shows AA carriers have lower circulating leptin levels relative to body fat percentage compared to G allele carriers, indicating more efficient leptin receptor responsiveness.

AG “Intermediate Leptin Function” Intermediate Caution

One copy of the leptin receptor variant — modestly reduced satiety signaling

The heterozygous state means approximately half your leptin receptors carry the Q223 form and half carry R223. In practice, this likely produces a mild reduction in overall leptin signaling efficiency compared to AA homozygotes. Population studies consistently place AG carriers at an intermediate position for BMI, body fat percentage, and circulating leptin levels. The effect size is modest — your genotype explains perhaps 1–2% of variance in body composition.

The most actionable finding is that AG carriers appear to benefit from protein-forward eating patterns that leverage leptin's macronutrient-selective satiating effects, and from avoiding late-night eating that disrupts the circadian leptin rhythm.

GG “Altered Leptin Receptor” Reduced Warning

Two copies of the leptin receptor variant — elevated leptin levels with reduced satiety signaling efficiency

The double arginine substitution at codon 223 places two positively charged amino acids in the extracellular leptin-binding loop where the wild-type receptor has neutral glutamine residues. While rigorous in vitro studies found no difference in STAT3 activation between Q223 and R223 receptors in controlled cell systems, human population data consistently show GG carriers have elevated circulating leptin that fails to proportionally suppress appetite — the defining feature of leptin resistance.

The mechanism may involve receptor trafficking, internalization kinetics, or cooperative binding effects that are not captured in simple in vitro assays. Alternatively, Q223R may be in near-perfect linkage disequilibrium with a truly functional regulatory or structural variant.

The variant's effects appear most pronounced in environments of energy excess. Among lean individuals, GG and AA genotypes show minimal phenotypic difference. Among overweight individuals, GG carriers show significantly higher BMI and waist circumference — suggesting a gene-environment interaction where the variant's effects only manifest under conditions of chronic positive energy balance.

Women with GG may face additional implications via the leptin-reproductive axis: the G allele is associated with PCOS susceptibility in Asian populations and with earlier menarche, reflecting leptin's role in signaling the hypothalamus that sufficient energy is available for reproduction.

Key References

PMID: 18997673

Functional study in humanized mouse model: Q223R had no effect on STAT3 signaling, body weight, or energy expenditure

PMID: 38625203

2024 meta-analysis of 39 studies (6099 cases/6711 controls): GG vs AA shows OR=1.39 for obesity, significant across Asian and Caucasian subgroups

PMID: 31948470

Sri Lankan cohort: GG carriers showed 1.3 kg/m² greater BMI and 3.8 cm greater waist circumference vs AA in overweight subjects

PMID: 31412346

Meta-analysis: rs1137101 significantly associated with PCOS susceptibility, particularly in Asian populations

PMID: 21159927

Spanish cohort: GG genotype associated with significantly earlier age at menarche (11.5 vs 12.0 years in QQ)

PMID: 36943722

Systematic review and meta-analysis: Q223R significantly associated with breast cancer susceptibility